SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.75    0.00 (0.00%)
Bid:
3.50
Ask:
4.00
Spread: 0.50 (14.286%)
Market Cap: £1.04m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

Director Declaration

19 Dec 2011 10:54

RNS Number : 2301U
Sabien Technology Group PLC
19 December 2011
 



19th December 2011

 

 

Sabien Technology Group plc

("Sabien" or "the Company")

 

 

Karl Monaghan, Non-Executive Director, has confirmed to the Company that Peacock Blue Home Limited , a company of which he was a Non Executive director was placed in administration on 12 November 2008 and Metanova Limited, a company of which he was a Non Executive director, was put into liquidation on 14 March 2008.

Save as disclosed above, there is no further information to be disclosed under the AIM Rules.

 

 

For further information:

 

Sabien Technology Group plc

 

Alan O'Brien, CEO

Gus Orchard, CFO

 

 

Tel: +44 (0) 20 7993 3700

www.sabien-tech.co.uk

 

Altium

 

Adrian Reed

Phil Frame

 

 

 

 

Tel: +44 (0) 845 505 4343

www.altiumcapital.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDNKMMMZGLMGMZM
Date   Source Headline
9th Jan 20247:00 amRNSTrading Update
29th Nov 20231:00 pmRNSResult of AGM
29th Nov 20237:30 amRNSAGM Statement
21st Nov 20231:30 pmRNSHolding(s) in Company
3rd Nov 20234:50 pmRNSHolding(s) in Company
2nd Nov 20231:34 pmRNSHolding(s) in Company
2nd Nov 20237:00 amRNSFinal Results & Annual Report & Accounts for 2023
1st Nov 20237:15 amRNSUpdate on 2023 Audited Accounts
4th Oct 20237:00 amRNSM2G Rollout in US
26th Sep 20237:00 amRNSProton Technologies
22nd Sep 20236:00 pmRNSHolding(s) in Company
6th Jul 20237:00 amRNSTrading Update
8th Jun 20237:00 amRNSM2G Business Update
16th May 20237:00 amRNSFurther update on b.grn and related matters
17th Apr 20237:00 amRNSUpdate on b.grn
13th Apr 20239:15 amRNSHolding(s) in Company
6th Apr 20237:00 amRNSDirector/PCA Shareholding
5th Apr 20235:00 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSInterim Results for the 6 months to 31 Dec 2022
28th Mar 20237:00 amRNSMaterial M2G Order & Business Update
27th Mar 20237:00 amRNSM2G supports Empiric on net zero goals
10th Mar 202311:33 amRNSHolding(s) in Company
10th Mar 202311:30 amRNSHolding(s) in Company
10th Mar 20237:00 amRNSMaterial M2G order and M2G trading update
28th Feb 20232:45 pmRNSHolding(s) in Company
6th Feb 20234:30 pmRNSHolding(s) in Company
2nd Feb 20234:51 pmRNSHolding(s) in Company
22nd Nov 202212:00 pmRNSResult of AGM
22nd Nov 20227:30 amRNSInvestor Update & Annual General Meeting Statement
18th Nov 20221:46 pmRNSHolding(s) in Company
10th Nov 20227:00 amRNSInvestor Update Presentation
2nd Nov 20227:00 amRNSSupply of UK's First Regenerative Green Oil System
24th Oct 20227:00 amRNSOrder Update – New Channel Partner & Customer
17th Oct 20222:47 pmRNSHoling(s) in Company
17th Oct 20221:54 pmRNSHolding(s) in Company
17th Oct 20227:00 amRNSHoling(s) in Company
17th Oct 20227:00 amRNSInternational Environmental Trae Summit Upate
17th Oct 20227:00 amRNSInternational Environmental Trade Summit Update
17th Oct 20227:00 amRNSHolding(s) in Company
14th Oct 20227:00 amRNSFinal Results for the Year to 30 June 2022
12th Oct 20227:00 amRNSHolding(s) in Company
5th Oct 20223:33 pmRNSHolding(s) in Company
23rd Sep 20222:49 pmRNSHolding(s) in Company
20th Sep 20224:16 pmRNSHolding(s) in Company
16th Sep 20227:00 amRNSRevised Date for Summit for S'th Korean Delegation
31st Aug 20225:00 pmRNSTotal Voting Rights
25th Aug 20223:30 pmRNSAdmission to trading of new Ordinary Shares
22nd Aug 20226:24 pmRNSResult of General Meeting
19th Aug 20227:00 amRNSSales Channel Partnership
16th Aug 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.